[Treatment of myasthenia gravis pseudoparalytica; clinical testing and therapy with BC substances (BC40, BC47, BC48 and BC 51)].
D008725:Bis-Trimethylammonium Compounds / Q000628:therapy*; D009157:Myasthenia Gravis / Q000628:therapy*; D009388:Neostigmine / Q000031:analogs & derivatives*
D008725:Bis-Trimethylammonium Compounds; D009388:Neostigmine
METHONIUM COMPOUNDS/therapy; MYASTHENIA GRAVIS/therapy; NEOSTIGMINE/related compounds